RecruitingPhase 2NCT06137274

Phase 2 Trial of Adaptive Radiotherapy Boost for HNSCC

Phase 2 Trial of Adaptive Radiotherapy Boost for Head and Neck Squamous Cell Carcinomas

Sponsor

H. Lee Moffitt Cancer Center and Research Institute

Enrollment

35 participants

Start Date

Dec 14, 2023

Study Type

INTERVENTIONAL

Conditions

Head and Neck Cancer Squamous Cell Carcinoma

Summary

The purpose of the study is to determine if it is feasible to use magnetic resonance imaging (MRI) to adjust a portion of radiation therapy for patients with head and neck squamous cell carcinoma . The technique under study will be used to personalize the study treatment based on response, keeping all treatments within standard of care guidelines.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Intensity-modulated radiotherapy and Magnetic Resonance Guidance for people with head and neck cancer and squamous cell carcinoma. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

RADIATIONIntensity-modulated radiotherapy

All patients will be treated with intensity-modulated radiotherapy (IMRT) plans.

OTHERMagnetic Resonance Guidance

All patients will undergo combined CT and/or MR simulation and will be treated with a sequential-boost technique.

Locations(1)

Moffitt Cancer Center

Tampa, Florida, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06137274

Related Trials

To Assess the Correlation of High-resolution Specimen PET-CT Imaging, Using the XEOS AURA 10 PET-CT, With the Histopathology Results and Long-term Outcome of Patients Undergoing Resective Cancer Surgery.

NCT069702754 locations

SGRT in Head and Neck Cancer Radiotherapy

NCT077264071 location

A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors

NCT0709049930 locations

DESTINY-PANTUMOUR04

NCT0712400018 locations

Phase I Study of Preconditioning Radiation Therapy With IL-15 Transduced TGFBR2 KO CAR.TROP2-engineered Cord Blood-derived NK Cells in Patients With Advanced Head and Neck Cancer (RADIANCE-NK)

NCT071014321 location